Phthalazinone

Phthalazinone

SCHEMBL2962226

O=c1[nH]ncc2ccccc12.[Pt]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.96
HSD17B10 Q99714 2/20 0.96
TDP1 Q9NUW8 2/20 0.96
ALDH1A1 P00352 1/20 0.96
PRKCI P41743 1/20 0.96
PDE4B Q07343 1/20 0.96
MAPK1 P28482 1/20 0.57
HSP90AA1 P07900 1/20 0.48
IDO1 P14902 1/20 0.48
CDK2 P24941 1/20 0.48
PRMT5 O14744 1/20 0.43
ABCB1 P08183 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
CYP1A2 P05177 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 2/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalazinone SCHEMBL51553 0.98 PARP1 (1.00) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL11516875 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL2473799 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL11519239 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL9617397 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL11519244 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL11690359 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL11516881 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL4663241 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI
Phthalazinone SCHEMBL29438173 0.96 PARP1 (0.96) PARP1HSD17B10TDP1ALDH1A1PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759488-B2 Monoazole ligand platinum analogs BIONUMERIK PHARMACEUTICALS, INC. (US) 2010-07-20 US claimed
US-7759488-B2 Monoazole ligand platinum analogs BIONUMERIK PHARMACEUTICALS, INC. (US) 2010-07-20 US disclosed
US-20070004696-A1 cis-aminedichloro [1-(phenylsulfonyl)-1H-benzotriazole] platinum for complexing with DNA and/or RNA BIONUMERIK PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004696-A1 cis-aminedichloro [1-(phenylsulfonyl)-1H-benzotriazole] platinum for complexing with DNA and/or RNA POLRMT, LUC7L2, NSUN3 PARP1 241/4885HSD17B10 2799/4885TDP1 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.